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Abstract
Background: Danshen-Gegen decoction (DG), a Chinese herbal formula, has been demonstrated to be effective for
the treatment of coronary heart disease such as myocardial infarction. In the present study, we investigated the
effect of DG post-conditioning on isoproterenol (ISO)-induced myocardial injury in rats.
Methods: ISO was injected intraperitoneally (200 mg/kg) to induce acute (2-6 hours) myocardial injury in adult
female rats. DG (4 g/kg) was administered per oral immediately after the injection of ISO in the rats. Extent of
myocardial injury was assessed by measurements of plasma enzyme activities. Myocardial mitochondrial
glutathione antioxidant status, lipid peroxidation and mitochondrial calcium ion loading and cytochrome c release
were also measured. Effects of inhibitors of protein kinase C-epsilon (PKCε) ranslocation and mitochondrial
ATP-sensitive potassium channel (mKATP) on myocardial post-conditioning by DG were investigated.
Results: ISO inflicted acute myocardial injury in the rats as evidenced by increased plasma enzyme activities. DG
post-treatment alleviated the ISO-induced acute myocardial injury.
Conclusion: DG post-treatment protected the myocardium against ISO-induced acute injury in rats. The myocardial
post-conditioning by DG is likely mediated by PKCε/mKATP signaling pathway.
Background
Atherosclerosis, which may occur in the coronary artery
and is linked to the pathogenesis of coronary heart dis-
ease (CHD), involves the deposition of plaque-forming
biomolecules (cholesterol and triglycerides in particular)
onto the inner wall of arteries. The atherosclerotic cor-
onary artery restricts nutrient and oxygen supply to the
myocardium, with resultant ischemia and eventual irre-
versible tissue damage if the ischemic episode is pro-
longed with or without reperfusion [1,2].
Radix Salviae Miltiorrhiza (Danshen)a n dRadix Puer-
ariae Lobatae (Gegen) are popular Chinese medicinal
herbs used in China, Japan and Korea for the treatment
of angina pectoris [3] and myocardial infarction [4,5].
Moreover, Danshen-Gegen (DG) decoction has long
been used to treat CHD [6]. Previous studies reported
that raw Danshen and Gegen and their isolated com-
pounds produced beneficial effects on cardiovascular
function in humans [7], rodents [8] and cultured human
endothelial cells [5]. Our recent ex vivo study demon-
strated that an aqueous extract of DG preconditioned
myocardium against ischemia/reperfusion injury in rats
[9]. However, whether the DG extract can exert any
direct beneficial effect on the myocardium immediately
after ischemic or oxidative challenge remains to be
investigated. The cardioprotection by ischemic post-con-
ditioning is likely linked to the activation of an adeno-
sine-mediated reperfusion-injury salvage kinase (RISK)
pathway [10] and a tumor necrosis factor-a-mediated
survivor activating factor enhancement (SAFE) pathway
[11]; both signaling pathways may target mitochondria
via the activation of protein kinase C-epsilon (PKCε),
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sium channel (mKATP), leading to inhibition of a mito-
chondrial permeability transition and ultimately
cardioprotection [12-16].
Isoproterenol [ISO, 1-(3,4-dihydroxyphenyl)-2-isopro-
pylaminoethanol hydrochloride (7)] is a synthetic cate-
cholamine and a potent b1/b2-adrenergic receptor
agonist [17]. A single administration of ISO at large
doses or multiple administrations at lower doses could
induce myocardial infarction, presumably due to the
generation of reactive oxygen species (ROS) through
auto-oxidation [18]. ISO-induced myocardial necrosis
was associated with alterations in membrane permeabil-
ity and the subsequent disruption of structural and
functional integrity of myocardial membranes [19]. ISO-
induced pathophysiological and morphologic alterations
in rat hearts resembled clinical manifestations of myo-
cardial infarction in humans [10,20,21].
The present study investigates the effects of myocar-
dial post-conditioning by DG in a rat model of ISO-
induced acute myocardial injury. Inhibitors of PKCε
translocation and mKATP were used to study the under-
lying mechanism(s) of myocardial post-conditioning-
induced by DG treatment.
Methods
Materials
Radix Salviae Miltiorrhiza and Radix Puerariae Lobatae
were purchased from Si Chuan Zhong Jiang Xiang
(Sichuen and Yang Jiang, Gaungdong, China) respec-
tively and authenticated by an herbalist working for the
Institute of Chinese Medicine (ICM) at The Chinese
University of Hong Kong by morphological characteriza-
tions and thin layer chromatography in accordance with
the Chinese Pharmacopoeia [22]. Voucher specimens of
Radix Salviae Miltiorrhiza (#2008-3088b) and Radix
Puerariae Lobatae (#2008-3167b) were deposited in the
ICM. DG extract (Danshen and Gegen,7 : 3 ,w / w )o fa n
optimized ratio as assessed by cardioprotection against
ischemia/reperfusion injury [9] was prepared in large-
scale for experimental and clinical investigations. Herbs
were soaked in water (1:10, w/v) for 75 min, followed by
extraction in boiling water for 60 min. The extraction
procedure was repeated twice with boiling water (1:8)
for 60 min and 30 min. The pooled aqueous extracts
were concentrated under reduced pressure at 60°C and
the concentrate was spray-dried to obtain the powdered
form of DG extract with a yield of 10.1%.
Chemical analysis of the DG extract
Major components in the DG extract were identified
and quantified according to our previous study with
minor modifications in terms of instrument and chro-
matographic conditions [23]. Briefly, a Waters high
performance liquid chromatography (HPLC) system
(Waters, USA) equipped with a 2695 solvent delivery
module and a 996 photodiode UV detector was used.
The chromatographic separation of the analytes was
achieved by an Agilent Eclipse XDB-C18 column (5250
×4 . 6m m ;5μm particle size, Agilent Technologies,
USA) connected to an Agilent C18 guard column (Agi-
lent Technologies, USA). The mobile phase consisting
of 0.5% acetic acid in acetonitrile (solvent A) and 0.5%
acetic acid in water (solvent B) was run with gradient
elution at a flow rate of 1 mL/min. The linear gradient
elution was carried out as follows: solvent A was kept at
5% for the first 5 min and increased to 10%, 17%, 35%
and 90% in the next 13 min, 12 min, 10 min and 3 min
respectively; it was then returned to 5% in 5 min and
equilibrated for 15 min before the next injection. HPLC
analysis indicated that the DG extract contained the fol-
lowing marker compounds (μg/100 mg; mean ± SD, n =
3): danshensu (1868.2 ± 33.7), salvianolic acid B (1345.7
± 18.5), protocatechuic aldehyde (78.3 ± 3.9), puerarin
(1760.1 ± 23.4), daidzein 8-C-apiosyl-glucoside (404.1 ±
8.1), daidzin (159.4 ± 3.3) and daidzein (162.9 ± 1.4).
Pharmacokinetics studies indicated that only danshensu,
puerarin and daidzein were detectable in plasma at 30
min after oral administration of DG extract to rats at a
dose of 0.15 g/kg (unpublished data).
Animals
Adult female Sprague-Dawley rats (8-10 weeks; 175-225
g) were housed in an air/humidity-controlled room with
12-hour dark-light cycle at approximately 22°C and
allowed food and water ad libitum in the Animal and
Plant Care Facility of the Hong Kong University of
Science and Technology (HKUST) throughout the
experiments. All experimental procedures were
approved by the Research Practice Committee at the
HKUST.
Induction of acute myocardial injury
Animals were randomly assigned to various groups of
six animals in each for the induction of myocardial
injury with or without post-treatment with the DG
extract. Animals received an intraperitoneal (ip) injec-
t i o no fI S O( S i g m a - A l d r i c h ,U S A )a tas i n g l ed o s eo f
200 mg/kg for the induction myocardial injury [24]. Pre-
liminary studies indicated that the ISO administration
increased plasma enzyme activities within six hours in
the rats. Control animals received the vehicle (saline)
only. Blood samples were obtained from phenobarbital-
anesthetized (120 mg/kg, ip) rats at increasing time
intervals (2, 4 and 6 hours) post-ISO administration.
These rats were then sacrificed by cardiac excision.
Myocardial ventricular tissue samples were obtained for
the preparation of cytosolic and mitochondrial fractions
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activities and myocardial mitochondrial parameters were
obtained from animals sacrificed immediately after the
injection of saline.
DG post-treatment protocol
Animals were intragastrically administered with the DG
extract at a dose of 4 g/kg immediately after intraperito-
neal injection of ISO in the rat model of ISO-induced
acute myocardial injury. Preliminary studies indicated
that oral administration of the DG extract at 2 g/kg did
not produce any detectable changes in plasma enzyme
activities four hours after intraperitoneal injection of
ISO in rats.
Inhibitors of PKCε and mKATP
PKCε translocation inhibitor (Calbiochem, Germany,
CAT# 539522) and 5-hydroxydecanoate (5-HD) (Sigma-
Aldrich Chemical, USA; CAT# H135), which are inhibi-
tors of PKCε and mKATP respectively, were dissolved in
DMSO at a concentration of 400 μg/mL. Rats were
injected (ip) with the inhibitor(s) at 400 μgp e rk go f
body weight for one hour prior to the intragastric
administration of DG extract or vehicle. Control animals
received 1.6% DMSO in saline.
Preparation of plasma samples and myocardial
mitochondrial/cytosolic fractions
Blood was drawn from phenobarbital-anesthetized rats
by cardiac puncture into a syringe rinsed with 5%
Na2EDTA as anti-coagulant (10%, v/v). The blood sam-
ple was centrifuged (Himac CF 9RX, Hitachi Koki Co.,
Ltd., Japan) at 600 × g for 10 min at 4°C. The superna-
tants were collected as plasma samples.
Myocardial ventricular tissue samples were rinsed with
ice-cold isotonic buffer (210 mM mannitol, 70 mM
sucrose, 5 mM HEPES, 1 mM EGTA, pH7.4, 0.2 mg/
mL soybean trypsin inhibitor, 0.2 mg/mL bacitracine,
0.16 mg/mL benzamidine). Tissue homogenates were
prepared by homogenizing 0.6 g of minced tissue in 6
mL ice-cold isotonic buffer in a Teflon-in glass homoge-
nizer (Glas-Col, USA) at a speed of 1600 rpm for 20
strokes on ice. The homogenates were centrifuged
(Himac CF 9RX, Hitachi Koki Co., Ltd., Japan) at 600 ×
g for 20 min at 4°C. Pellets collected from the superna-
tant were resuspended with the same volume of ice-cold
homogenizing buffer (but without the protease inhibi-
tors) and re-centrifuged (Himac CF 9RX, Hitachi Koki
Co., Ltd., Japan) at 600 × g. The procedure was repeated
twice. After pooled supernatants (4 volumes total) were
centrifuged (Himac CR21G, Hitachi Koki Co., Ltd.,
Japan) at 9200 × g for 30 min, the mitochondrial pellets
were collected. The supernatants were saved for the pre-
paration of cytosolic fractions. The mitochondrial pellets
were then washed with the same volume of ice-cold
sucrose buffer (210 mM mannitol, 70 mM sucrose, 5
mM HEPES-KOH; pH7.4) and the mixtures were centri-
f u g e da t9 , 2 0 0×g for 30 min. The washing procedure
was repeated once. The mitochondrial pellets were
resuspended in 1.0 mL of ice-cold sucrose buffer and
constituted the mitochondrial fractions. Cytosolic frac-
tion was prepared from the above supernatant was cen-
trifuged (Optima TLX Ultracentrifuge 120, Beckman
Coulter Inc., USA) at 100,000 × g for 60 min at 4°C.
Biochemical analysis
Lactate dehydrogenase (LDH) activity in plasma sample
was measured as described by Vanderlinde [25]. Plasma
aspartate aminotransferase (AST) activity was measured
with an assay kit (Sigma-Aldrich Chemical, USA). An
aliquot (180 μL) of reconstituted AST assay solution
was mixed with 20 μLp l a s m as a m p l ei na9 6 - w e l l
micro-titer plate. Absorbance changes of the reaction
mixture in a final volume of 200 μL were monitored
with a Victor
3 Multi-Label Counter (Perkin-Elmer,
USA) at 340 nm for 5 min at 37°C. Plasma creatine
phosphokinase (CPK) activity was measured with an
assay (Sigma-Aldrich Chemical, USA). An aliquot (200
μL) of reconstituted CPK assay solution was mixed with
5 μL plasma sample in a 96-well micro-titer plate.
Absorbance changes of the reaction were monitored
with a Victor
3 Multi-Label Counter (Perkin-Elmer,
USA) at 340 nm for 5 min at 37°C. Aliquots (210 μL) of
mitochondrial fractions were measured for reduced glu-
tathione (GSH) according to a method by Griffith [26].
Aliquots (250 μL) of mitochondrial fractions were mea-
sured for the malondialdehyde (MDA) level, an indirect
index of lipid peroxidation according to an HPLC
method by Cheng et al. [27]. Mitochondrial glutathione
reductase (GRD) and Se-glutathione peroxidise (GPX)
activities were measured as described by Chiu et al.
[28]. Mitochondrial isocitrate dehydrogenase (ICDH)
activity was measured according to the method by
Popova et al. [29]. Plasma and mitochondrial parameters
were expressed as the percentage of control (ie basal
value in saline injected animals). Basal values of plasma
and mitochondrial parameters were shown in Table 1.
Time-dependent changes in plasma enzyme activities
and mitochondrial antioxidant components as well as
MDA production were quantified according to the area
under/or above the curve. Effects of DG post-treatment
on ISO-induced changes were expressed in percentage
(%) of protection in relation to the corresponding data
obtained from DG-untreated animals.
Mitochondrial Ca
2+ content was determined by a
Ca
2+-sensitive fluorescence probe Fluo-5N AM ester
(Molecular Probe, USA) on a Victor
3 Multi-Label
Counter (Perkin-Elmer, USA) [30]. The Ca
2+
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2+
calibration kit (Molecular Probe, USA) in a range of 1-
1000 μM, with an estimated Kd value of 98 μM, which
was in good agreement with the data provided by the
manufacturer. An aliquot (25 μL) of mitochondrial frac-
tion (0.5 mg/mL final concentration) was mixed with 25
μL of incubation buffer (100 mM KCl and 30 mM
MOPS; pH7.2) in 96-well black micro-titer plate. The
mixture was incubated at 25°C for 15 min and then 25
μL digitonin (50 μg/mL) and 25 μLF l u o - 5 NA Me s t e r
(1 μMi n0 . 0 0 5 %P l u r o n i cF - 1 2 7 )w e r ea d d e dt ot h e
mixture. This reaction mixture was incubated at 25°C
for 30 min; the fluorescence was measured at 488 nm
(excitation) at 532 nm (emission). The mitochondrial
Ca
2+ content was estimated with a standard calibration
curve and presented in μmol/mg of protein.
Mitochondrial cytochrome c release was indirectly
assessed by the measurement of cytosolic cytochrome c
levels using Western blot analysis [31]. Total cytosolic
fractions with equal amounts of protein (40 μg of protein)
were subjected to 15% SDS-PAGE, followed by immuno-
blotting using specific antibodies of cytochrome c (clone
7H8.2C12, BD PharMingen, USA). The extent of mito-
chondrial contamination in the cytosolic fractions, which
was determined using specific antibodies against complex
IV and complex IV protein band, was undetectable in
cytosolic fractions (data not shown). The protein-blot ana-
lysis was performed with an ECL Western Blotting System
(Cell Signaling Technology, USA) and the protein bands
were quantified by densitometry. The cytochrome c
release was estimated from the amount (arbitrary units) of
cytochrome c normalized with reference to actin (1:5000,
Sigma Chemical, USA) levels (arbitrary units) in the
sample.
Protein assay
Protein concentration was determined with a Bio-Rad
p r o t e i na s s a yk i t( U S A ) .A na l i q u o t( 1 0μL) of diluted
mitochondrial or cytosolic sample was added to the
wells of a 96-well micro-titer plate; then 200 μLo f
5-fold diluted Bio-Rad assay reagent was added. The
m i x t u r ew a ss t o o da tr o o mt e m p e r a t u r ef o r5m i n .
Absorbance of the mixture was measured at 570 nm.
Protein concentration was determined with a calibration
curve using bovine serum albumin as standard.
Statistical analysis
Data were analyzed by one-way ANOVA. Post-hoc tests
for pair-wise multiple comparisons were done with
Least Significant Difference test with SPSS statistical
software (SPSS, USA). Comparisons between two groups
were performed with Student’s t test. Statistical signifi-
cance was determined at P value < 0.05.
Results
Effects of DG post-treatment on plasma enzyme activities
in ISO-challenged rats
As shown in Figure 1a, ISO treatment caused time-
dependent increases in plasma enzyme activities, indica-
tive of myocardial injury, with the maximal stimulation
at four hours post-ISO challenge. At six hours after
post-ISO challenge, the plasma enzyme activities were
still significantly higher (144-162%; P <0 . 0 0 1 )t h a nt h e
basal values of animals receiving only saline injection.
DG treatment (4.0 g/kg) immediately after the ISO chal-
lenge decreased the extent of increases in plasma
enzyme activities. From the time-dependent changes in
plasma enzyme activities as quantified by the area under
the curve (AUC), we found that DG post-treatment pro-
tected against the ISO-induced increases in plasma
enzyme activities by 32% (LDH; P = 0.033), 21% (AST;
P < 0.001) and 19% (CPK; P=0.046) (Figure 1b).
Effects of DG post-treatment on mitochondrial
glutathione antioxidant status and lipid peroxidation in
ISO-challenged rat hearts
The ISO-induced myocardial injury was associated with
an impairment in myocardial mitochondrial antioxidant
status in rats, as evidenced by the time-dependent and
biphasic changes in GSH level as well as GRD and GPX
activities, with the maximal degree of inhibition 26-28%;
P < 0.001) at four hours after post-ISO challenge
(Figure 2a). The mitochondrial ICDH activity was also
suppressed but showed an early recovery two hours
after the ISO challenge. The ISO-induced impairment in
mitochondrial glutathione antioxidant status was
paralleled by an increased extent of mitochondrial
lipid peroxidation in rat hearts, as indicated by the
time-dependent increase in MDA production, with the
maximal stimulation (54%; P < 0.001) at four hours after
ISO challenge. The protection against ISO-induced
Table 1 Basal values of plasma enzyme activities and myocardial mitochondrial antioxidant parameters in rats
LDH AST CPK GSH GR GPX ICDH MDA
U/L nmol/mg protein mU/mg protein pmol/mg protein
Mean (SD)
(n =6 )
129.8 (10.8) 31.2 (2.68) 158.1 (20.4) 4.3 (0.25) 2.4 (0.24) 2.8 (0.26) 308.8 (23.0) 90.5 (5.39)
Plasma lactate dedydrogenase (LDH), aspartate aminotransferase (AST) and creatine phosphokinase (CPK) activities, as well as myocardial mitochondrial reduced
glutathione (GSH) level and glutathione reductase (GR), Se-glutathione peroxidase (GPX), and isocitrate dehydrogenase (ICDH) activities, and malodialdehyde
(MDA) level were measured in rats immediately after an intraperitoneal injection of saline.
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associated with the improvement in myocardial mito-
chondrial glutathione antioxidant status, as assessed by
GSH level (35%; P = 0.002) (% protection with respect
to non-DG-treated and ISO-challenged rats), GRD (45%;
P = 0.008), GPX (36%; P < 0.001) and ICDH (68%; P <
0.001) activities as well as the suppression of mitochon-
drial lipid peroxidation (41%; P=0.019) (Figure 2b).
Effects of DG post-treatment on mitochondrial Ca
2+
loading and cytochrome c release in ISO-challenged rats
ISO challenge increased mitochondrial Ca
2+ content
(45%; P < 0.001) and cytochrome c release (98%; P <
0.001) at four hours after ISO challenge in rat hearts
(Figure 3). While DG treatment did not affect mito-
chondrial Ca
2+ content and cytochrome c release, it sig-
nificantly decreased the extent of ISO-induced increases
in mitochondrial Ca
2+ level and cytochrome c release,
with the degree of protection at 56% (P =0 . 0 0 2 )a n d
52% (P = 0.005) respectively.
Effects of PKCε and mKATP inhibitors on myocardial
protection by DG post-treatment
To investigate the signaling pathway involved in the DG-
induced myocardial protection, we examined the effects
of PKCε and mKATP on myocardial protection against
ISO-induced injury by DG post-treatment in rats (Figure
4). The ISO-induced myocardial injury was assessed at
four hours after ISO challenge. While the treatment with
PKCε translocation inhibitor (400 μg/kg, ip) did not
affect the ISO-induced myocardial injury, it completely
abrogated the cardioprotection by DG post-treatment,
with the degree of myocardial injury slightly higher than
that of DG-untreated and ISO-challenged animals. The
administration of mKATP blocker (5-HD, 400 μg/kg, ip)
also did not affect the ISO-induced myocardial injury but
A
B
Figure 1 Effects of DG-post-treatment on plasma enzyme activities in ISO-challenged rats. Animals were administered intraperitoneally
with isoproterenol (ISO) at a dose of 200 mg/kg. Control animals received an injection of saline. DG extract was administered per oral at a dose
of 4 g/kg immediately after the ISO challenge. Animals were sacrificed at increasing time intervals (2, 4, 6 hours) after ISO challenge. (A) Plasma
lactate dehydrogenase (LDH), asparate aminotransferases (AST) and creatine phosphokinase (CPK) activities were measured. (B) The degree of
protection against ISO-induced increases in plasma enzyme activities in DG-treated animals was estimated as described in Methods. Values are
means ± SD (n = 6). * Significantly different from animals receiving saline injection without ISO;
# significantly different from the time-matched
ISO-challenged animals without DG post-treatment.
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against ISO challenge, with a much higher extent of myo-
cardial injury than that of DG-untreated and ISO-chal-
lenged rats.
Discussion
As the pathological changes of myocardial injury caused
by acute or multiple ISO treatment resemble the clinical
manifestations of myocardial infarction [10,20,21], eg the
ISO-induced necrotic cells’ leakage of housekeeping
enzymes such as LDH, AST and CPK from the myocar-
dium to blood, the measurement of these enzyme activ-
ities is a reliable assessment for the extent of ISO-
induced myocardial injury. Our results showed that ISO
administration inflicted acute myocardial injury in rats
and that DG treatment immediately after the ISO chal-
lenge protected the myocardium against such injury.
Preliminary studies indicated that histological changes
A
B
Figure 2 Effects of DG post-treatment on mitochondrial glutathione status and lipid peroxidation in ISO-challenged rat hearts.( A )
Mitochondrial reduced glutathione (GSH) level, glutathione reductase (GR), Se-glutathione peroxidase (GPX) and isocitrate dehydrogenase (ICDH)
activities as well as malondialdehyde (MDA) level were measured. (B) The degree of protection against ISO-induced changes in mitochondrial
parameters was estimated as described in Methods. Values are means ± SD (n = 6). * Significantly different from animals receiving saline
injection without ISO;
# significantly different from the time-matched ISO-challenged animals without DG post-treatment.
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infiltration were not observable in apical ventricular tis-
sue at four hours after ISO challenge in rats. Thus, we
did not include histopathological analysis in the present
study; however, another study indicated that DG treat-
ment at 24 hour after ISO challenge also protected
against myocardial damage in rats, as assessed by plasma
enzyme activities and histological parameters (unpub-
lished data). The development of ISO-induced myocar-
dial injury involves ROS-mediated processes [32].
Consistent with this, the ISO-induced myocardial injury
was accompanied by the impairment in mitochondrial
glutathione antioxidant status and the enhancement in
mitochondrial lipid peroxidation in rat hearts. Post-
treatment with the DG extract partially reversed the
altered myocardial mitochondrial antioxidant parameters
in ISO-challenged rats.
Impairment in mitochondrial glutathione antioxidant
status renders the cardiomyocytes more susceptible to
oxidative stress [33]. The imbalance between ROS gen-
eration and glutathione redox cycling may lead to
increased mitochondrial Ca
2+ loading, which eventually
leads to a mitochondrial permeability transition
(MPT). The opening of MPT pores is triggered by sti-
muli such as oxidants, high mitochondrial Ca
2+ con-
tent and/or depletion of adenine nucleotides [34].
MPT decreases mitochondrial ATP synthesis and
causes cytochrome c release from the mitochondrial
inner membrane, resulting inn e c r o t i ca n d / o ra p o p t o -
tic cell death [35]. In the rat model of ISO-induced
myocardial injury, DG post-treatment may inhibit
mitochondrial Ca
2+ uptake (as indicated by the
decrease in mitochondrial Ca
2+ level) and prevent the
onset of MPT (as indicated by the decrease in mito-
chondrial cytochrome c release), thereby protecting
against ISO-induced myocardial injury. The ability of
DG post-treatment to inhibit MPT may be related to
the enhancement in mitochondrial glutathione antioxi-
dant status [36]. While GPX suppresses the oxidation
of mitochondrial membrane lipids by removing
organic hydroperoxides generated from ROS-mediated
reactions [37], glutathione redox cycling, which
involves the GR- and ICDH-catalyzed reactions in
GSH regeneration and NAPDH production respec-
tively, can sustain the mitochondrial GSH level under
oxidative stress conditions [38].
The cardioprotection against ISO-induced injury by
DG post-treatment was abrogated by PKCε or mKATP
inhibition, suggesting the involvement of PKCε activa-
tion and mKATP opening in the process of myocardial
post-conditioning by DG. PKCε is a member of a novel
group of the PKC family of serine and threonine kinases
Figure 3 Effects of DG post-treatment on mitochondrial Ca
2+
loading and cytochrome c release in ISO-challenged rat hearts.
Animals were sacrificed at four hours after ISO challenge. Myocardial
mitochondrial Ca
2+ content and cytochrome c release were measured.
The lowest panel shows the representative immuno-stained band of
cytochrome c of myocardial cytosolic fractions prepared from various
experimental groups. The non-striped bar represents the non-ISO
challenged group and the striped bar represents the ISO-challenged
group. Values are means ± SD (n = 6). * Significantly different from the
non-ISO-challenged animals without DG treatment (ie CON);
†
significantly different from the ISO-challenged CON.
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Figure 4 Effects PKCε and mKATP inhibitors on myocardial protection afforded by DG post-treatment. Animals were sacrificed at four
hours after ISO challenge. PKCε translocation inhibitor and mKATP blocker (5-hydroxydecanoate, 5-HD) were intraperitoneally administered at a
dose of 400 μg/kg one hour prior to the administration of the DG extract. Plasma enzyme activities and myocardial mitochondrial antioxidant
parameters were measured as described in Figures 1 and 2. The non-striped bar represents the non-ISO-challenged group and the striped bar
represents the ISO-challenged group. Values are means ± SD (n = 6). * Significantly different from the non-ISO-challenged CON;
# significantly
different from the ISO-challenged CON with inhibitors;
† significantly different from the respective ISO-challenged CON.
Wong et al. Chinese Medicine 2011, 6:7
http://www.cmjournal.org/content/6/1/7
Page 8 of 10that are involved in a wide range of physiological pro-
cesses including mitogenesis, cell survival under stressful
conditions, metastasis and transcriptional regulation
[39]. It has been postulated that the activation of RISK
and SAFE pathways involved in myocardial ischemic
post-conditioning might activate PKCε and mKATP,
thereby inhibiting the MPT [12-16]. The aggravation of
ISO-induced myocardial injury by DG treatment in the
presence of PKCε translocation inhibitor may be related
to the pro-oxidant action of DG. Moreover, the activa-
tion of signal transducers and activators of transcription
protein-3 (STAT-3) through the SAFE pathway
increased the transcription of antioxidant genes such as
those for g-glutamyl cysteine ligase (for GSH synthesis),
GRD and GPX [40-42] which are major determinants of
cellular/mitochondrial glutathione antioxidant status.
While the mitochondrial glutathione antioxidant status
was enhanced by DG post-treatment in ISO-challenged
rat hearts, our preliminary studies indicated that the
inhibition of STAT-3 completely abrogated the cardio-
protection against ISO-induced injury by DG post-treat-
ment in rats (unpublished data), implicating the
involvement of STAT-3 activation in DG myocardial
post-conditioning. Prior to an ischemic insult, treatment
with puerarin (0.24 mmol/L in perfusate for 5 min) or
daidzein (10 mg/kg, ip), both of which are ingredients in
the DG extract, conferred cardioprotection against
ischemia/reperfusion injury in rats both in vitro and in
vivo by opening calcium-activated potassium channel
and activating PKC or inhibiting nuclear factor-kappa B
activation respectively [43-45]. Interestingly, intravenous
administration of a mixture of puerarin and danshensu
prior to an ischemic insult also protected against myo-
cardial ischemia/reperfusion injury in rats through anti-
oxidant actions [8].
Conclusion
DG post-treatment protected the myocardium against
ISO-induced acute injury in rats. The myocardial post-
conditioning by DG is likely mediated by signal pathway
(s) inducing the activation of PKCε and mKATP.
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activators of transcription protein-3
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